Arachnova Therapeutics Limited
Arachnova portfolio strengthened with new patents for MCI-225
Published in Biotech Law Weekly, March 24th, 2006
Arachnova acquired a license to data relating to this compound from Mitsubishi Pharma Corp. in February 2004 and has patented new therapeutic uses for the compound.
The data include toxicological and other non-clinical information, which underpinned a substantial clinical program involving over 350 patients. The novel uses identified by Arachnova are therapeutic switch developments in a variety of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-03-24)
More Articles from Biotech Law Weekly
- Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals reports loss of $0.56 per share - Amarin Corp. plc
Amarin posts quarterly loss of $0.10 per share - AstraZeneca
Economic impact of acute ischemic stroke highlighted in new study - Baylor College of Medicine, Houston
Ethics of signing on to the medical-industrial complex are examined - California Coalition for Compassionate Access
California group launched to support medical marijuana - Cipher Pharmaceuticals, Inc.
CIP-Fenofibrate approval from Health Canada received by Cipher - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
